Biliary atresia is a congenital disorder of obstruction in the tubes (ducts) that transport bile from the liver to the gallbladder due to abnormal development of the bile ducts within or outside the liver. In infants with biliary atresia, bile cannot pass from the liver to the gallbladder, resulting in liver damage and cirrhosis and could be fatal if left untreated.
It is also known as extrahepatic ductopenia or progressive obliterative cholangiopathy.
The most common of the rare neonatal cholestatic syndromes, biliary atresia occurrence is seen in about one out of every 8,000-12,000 live births globally. It is mainly seen in female infants.
There are various types of biliary atresia classification.
Depending on its occurrence, there are two types of biliary atresia, which are:
Based on the location of the block and degree of pathology, the Kasai system of biliary atresia classification divides the ailment into three main types based on the anatomical position of the block (obliteration):
Type III is also called extrahepatic biliary atresia. Extrahepatic biliary atresia is most commonly associated with total and permanent cholestasis. Here the bile duct could be partially or blocked between porta hepatis and the duodenum, and the worldwide incidence could range from 1:8,000-1:10,000.
At birth, infants with biliary atresia may look healthy, but jaundice develops during the second or third week of life. The newborn may gain weight generally during the first month but will then lose weight, develop irritability, and have severe neonatal jaundice. The parents and caretakers are responsible for considering and comprehending the child's anomalies.
Other symptoms of biliary atresia may include:
The paediatricians particularly look for “biliary atresia poop", one of the confirming factors of steatorrhea.
The reason for biliary atresia occurrence is unknown, but it can be caused by immune, infectious/toxic, and genetic factors.
More of correlations rather than risk factors, a 2007 study published in the American Journal of Medical Genetics demonstrated the assessment from the statistics of the National Birth Defects Prevention Study (NBDPS) of America to understand the potential correlations which could have caused this ailment. It was shown that biliary atresia is more likely to occur.
The causes of biliary atresia are not known, but may include the following:
Although biliary atresia is not an inherited disease, a minority of cases could be caused due to morphogenetic defects (faultlines developed during the growth of the biliary tree & liver during pregnancy). A prenatal ultrasound exposing a cyst in the biliary system could diagnose the ailment during gestation.
Children suffering from biliary atresia consequently suffer from a reduction of bile flow into the small intestine leading to malnutrition, culminating with liver damage. The paediatricians may develop a unique eating plan containing enough nutrients, calories and supplements after consulting dietitians.
About 10% of infants suffering from biliary atresia also display other innate life-limiting fibro-obliterative anomalies such as:
The biliary atresia investigations include the following:
Biliary atresia (BA) is an obstructive neonatal cholangiopathy which leads to the development of end stage liver disease within the first 6–12 months.
Presently, there is no medical therapy to cease the continuity or reverse this cholangiopathy.
The hepatoportoenterostomy, introduced by Kasai in 50’s decade, till date remains the only glaring potential corrective operative procedure. The Kasai procedure results reinvigorated the biliary flow from the liver to the intestine. Untreated biliary atresia could lead to hepatic failure, progressive hyperbilirubinemia, cirrhosis, and death.
The medical anomaly of any tubular body part with no standard opening, thus not allowing any material to pass through it, is called atresia. It can occur in any duct ranging from the oesophagus to the anus and to the various blood vessels which run throughout the body.
If atresia occurs in any part or the whole of the biliary tree, it is called biliary atresia. It is also known as extrahepatic ductopenia or progressive obliterative cholangiopathy.
Extrahepatic biliary atresia, also known as obstructive fibroinflammatory cholangiopathy, was first described by John Thomson in 1892 in the medical article named “On Congenital Obliteration of the Bile-Ducts” published in the Scottish journal - The Transactions of the Edinburgh Obstetrical Society.
There are quite a few strategies implemented by the paediatrician to rule out every other possible disease which may show similar symptoms. After the symptoms, the paediatrician usually starts with a physical examination to see any signs of an enlarged liver. For confirmatory analysis, the other tests include:
The gold standard in the diagnosis of biliary atresia is liver biopsy. It has an accuracy of 88.2-96.9%.
Usually, the parents rush to the paediatrician once they notice the biliary atresia symptoms, which appear between 2-6 weeks. The other symptoms the parents may notice include: yellowing of the skin and the sclera of the eyes (jaundice), abnormally pale stools, dark urine etc.
You can check if your newborn has biliary atresia with prime symptoms such as jaundice extending three weeks of age and producing pale yellow, grey, or white stools.
The healthcare team led by surgical paediatricians may have to perform a surgery called the Kasai procedure to treat biliary atresia. Eventually, in most cases, a liver transplant may also be done. More than 80-90% of infants suffering from biliary atresia who received the treatment survive adulthood.
Yes. With timely treatment and proper care, and nutrition, biliary atresia patients can lead an everyday life with biliary atresia. Most of them are expected to live into adulthood with an excellent outlook for patients in the long term.
There is no medication to treat biliary atresia. A necessary lifesaving surgery called the Kasai procedure (also known as hepatoportoenterostomy) is performed, which clears the path of bile flow from the liver into the duodenum.
Due to the bile not being produced, there will be a severe shortage of oil-based vitamins, among other forms of malnutrition. The paediatricians often prescribe vitamin supplements such as vitamins A, D, E, and K and other essential nutrients even after the Kasai procedure to ensure the baby's growth.
Fill in the appointment form or call us instantly to book a confirmed appointment with our super specialist at 04048486868
Thank you for contacting us. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
Whatsapp: 8977889778
Regards,
Pace Hospitals
Hitech City and Madinaguda
Hyderabad, Telangana, India.
Oops, there was an error sending your message. Please try again later. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
Whatsapp: 8977889778
Regards,
Pace Hospitals
Hitech City and Madinaguda
Hyderabad, Telangana, India.
By clicking on Subscribe Now, you accept to receive communications from PACE Hospitals on email, SMS and Whatsapp.
Thank you for subscribing. Stay updated with the latest health information.
Oops, there was an error. Please try again submitting your details.
Payment in advance for treatment (Pay in Indian Rupees)
For Bank Transfer:-
Bank Name: HDFC
Company Name: Pace Hospitals
A/c No.50200028705218
IFSC Code: HDFC0000545
Bank Name: STATE BANK OF INDIA
Company Name: Pace Hospitals
A/c No.62206858997
IFSC Code: SBIN0020299
Scan QR Code by Any Payment App (GPay, Paytm, Phonepe, BHIM, Bank Apps, Amazon, Airtel, Truecaller, Idea, Whatsapp etc)
Disclaimer
General information on healthcare issues is made available by PACE Hospitals through this website (www.pacehospital.com), as well as its other websites and branded social media pages. The text, videos, illustrations, photographs, quoted information, and other materials found on these websites (here by collectively referred to as "Content") are offered for informational purposes only and is neither exhaustive nor complete. Prior to forming a decision in regard to your health, consult your doctor or any another healthcare professional. PACE Hospitals does not have an obligation to update or modify the "Content" or to explain or resolve any inconsistencies therein.
The "Content" from the website of PACE Hospitals or from its branded social media pages might include any adult explicit "Content" which is deemed exclusively medical or health-related and not otherwise. Publishing material or making references to specific sources, such as to any particular therapies, goods, drugs, practises, doctors, nurses, other healthcare professionals, diagnoses or procedures is done purely for informational purposes and does not reflect any endorsement by PACE Hospitals as such.